期刊文献+

新型冠状病毒肺炎疫情下国家药品抽检工作防控要点分析与建议 被引量:3

Key Points Analysis and Suggestions for the Prevention and Control of Coronavirus Disease 2019 Epidemic During National Drug Sampling and Testing
下载PDF
导出
摘要 目的为新型冠状病毒肺炎(简称新冠肺炎)疫情下做好国家药品抽检工提供参考。方法梳理国家药品抽检工作中的职业暴露环节,分析新冠肺炎疫情防控要点和继续做好防控工作所面临的形势,提出针对性建议。结果与结论目前,国家药品抽检工作中的新冠肺炎疫情防控状况良好,但疫情仍未解除。建议在下一步抽检工作中建议提高网络技术利用率,优化工作安排,全面落实防控措施,重视工作外的防控,继续做好新冠肺炎疫情防控。 Objective To provide reference for the prevention and control of the coronavirus disease 2019(COVID-19)epidemic during national drug sampling and testing.Methods The occupational exposure in the national drug sampling and testing was combed,the key points of the COVID-19 epidemic prevention and control were analyzed,the situation faced by the future prevention and control work was analyzed and the targeted suggestions were put forward.Results and Conclusion At present,the prevention and control work of COVID-19 epidemic is satisfactory during the national drug sampling and testing,but the epidemic situation has not yet been resolved.It is suggested to improve the utilization rate of network technology,optimize the work arrangements for drug sampling and testing,implement the prevention and control measures comprehensively,pay attention to the prevention and control in spare time,and continue to do a good job in epidemic prevention and control.
作者 刘文 王翀 朱炯 LIU Wen;WANG Chong;ZHU Jiong(National Institute for Food and Drug Control,Bejing,China 102629)
出处 《中国药业》 CAS 2020年第8期1-3,共3页 China Pharmaceuticals
关键词 新型冠状病毒肺炎 国家药品抽检 疫情防控 职业暴露 coronavirus disease 2019 national drug sampling and testing epidemic prevention and control occupational exposure
  • 相关文献

参考文献8

二级参考文献56

  • 1樊夏雷,夏玉成.完善制度体系 发挥文化效能——江苏省药检所努力促进药检工作健康发展纪事[J].中国食品药品监管,2010(2):69-70. 被引量:2
  • 2国家食品药品监督管理总局.《食品药品监管总局关于印发国家药品计划抽验质量分析指导原则的通知》(食药监药化监(2014]93号)[EB/OL].(2014-07-09).http://www.sda.gov.en/WS01/CL0844/102814.html.
  • 3国家食品药品监督管理总局.《食品药品监管总局发出警示函督促药品生产企业排查风险提升药品质量》[EB/OL].(2014-12-01).http://www.sda.gov.cn/WS01/CL0050/110044.html.
  • 4国家食品药品监督管理总局.《对广东怡康制药有限公司飞行检查情况》[EB/OL].(2014-11-15).http://www.sda.gov.cn/WS01/CLl681/109229.html.
  • 5PUERTOLLANO M, CARTWRIGHT T, AYLOTT M, et al. As- sessing an analytical method for the dissolution profile of an ex- tended-release tablet in accordance with QbD [ J ]. Tab Caps, 2009,7(1) :30 -39.
  • 6DAVID F, JACQ K, SANDRA P,et al. Analysis of potential genotoxic impurities in pharmaceuticals by two dimensional gas chromatography with Deans switching and independent column temperature control using a low-thermal-mass oven module [ J ]. Anal Bioanal Chem ,2010,396 ( 3 ) : 1291 - 1300.
  • 7FREDERICK GV,Alireza SK. Development of quality-by-design analytical methods[J]. J Pharm Sci,2011,100(3 ) :797 -812.
  • 8KOCHLING J, BRIDGEWATER J, NAJI R. Introducing a sci- ence-based quality by design concept to analytical methods devel- opment. Biotechnology: Pharmaceutical Aspects ( Pharmaceutical Stability Testing to Support Global Markets) [ M ]. Vol 12. New York : Springer,2010 : 169 - 179.
  • 9COGDILL RP, DRENNEN JK. Risk-based Quality by Design (QbD) : A taguchi perspective on the assessment of product qual- ity, and the quantitative linkage of drug product parameters and clinical performance [ J ]. J Pharm lnnov ,2008 ,3 ( 1 ) :23 - 29.
  • 10刘婷.从美国的凭单制度看金融危机背景下的“消费券”热潮[J].财会研究,2009(6):77-79. 被引量:6

共引文献248

同被引文献37

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部